These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 24709585

  • 1. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF.
    Vaccine; 2014 May 13; 32(23):2675-81. PubMed ID: 24709585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y.
    Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631
    [Abstract] [Full Text] [Related]

  • 5. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ.
    J Virol; 2001 Jan 25; 75(2):934-42. PubMed ID: 11134306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP.
    Virology; 1999 May 10; 257(2):363-72. PubMed ID: 10329547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel amino acid site closely associated with the neurovirulence of live, attenuated Japanese encephalitis vaccine (SA14-14-2 strain).
    Yang H, Fan F, Liu L, Liu J, Sun Y, Xie A, Shi X, Liu L, Yu Y, Li Y, Ge Y, Zeng X, Yang H.
    Vaccine; 2020 Mar 04; 38(11):2636-2642. PubMed ID: 32044162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice.
    Cao JX, Ni H, Wills MR, Campbell GA, Sil BK, Ryman KD, Kitchen I, Barrett AD.
    J Gen Virol; 1995 Nov 04; 76 ( Pt 11)():2757-64. PubMed ID: 7595383
    [Abstract] [Full Text] [Related]

  • 17. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
    Monath TP, Arroyo J, Levenbook I, Zhang ZX, Catalan J, Draper K, Guirakhoo F.
    J Virol; 2002 Feb 04; 76(4):1932-43. PubMed ID: 11799188
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characterization of chimeric duck Tembusu virus based on Japanese encephalitis live vaccine strain SA14-14-2.
    Wang HJ, Liu L, Li XF, Ye Q, Deng YQ, Qin ED, Qin CF.
    J Gen Virol; 2016 Jul 04; 97(7):1551-1556. PubMed ID: 27100268
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17.
    Shah PS, Tanaka M, Khan AH, Mathenge EG, Fuke I, Takagi M, Igarashi A, Morita K.
    Vaccine; 2006 Jan 23; 24(4):402-11. PubMed ID: 16303214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.